Sanofi
$39.92Change from previous close: −1.84%Absolute change: −$0.75
At a glance
- Revenue growth
- +5.49%
- 2025 vs 2024
- Net income growth
- +40.52%
- 2025 vs 2024
- Net margin
- 16.7%
- 2024: 12.6%
Financial data
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 2,960 | 1,683 | 3,445 | 3,750 | 1,462 | 2,093 | — | — |
| Depreciation and amortization | 1,239 | 535 | 2,019 | -279 | 821 | 748 | — | — |
| Capital expenditure | -882 | — | -1,762 | 845 | -845 | — | — | — |
| Investing cash flow | -365 | -2,278 | -2,131 | -9,043 | 9,503 | -776 | — | — |
| Financing cash flow | -1,805 | -1,527 | -2,570 | -1,148 | -3,897 | -592 | — | — |
| Dividends paid | -4,923 | — | -4,772 | — | -4,772 | — | — | — |
| Share repurchases | -1,009 | — | -5,030 | -29.0 | -4,003 | — | — | — |
| Debt issued | 4,259 | — | 5,559 | -6,315 | 6,315 | — | — | — |
| Debt repaid | -1,652 | — | -4,055 | 1,983 | -1,983 | — | — | — |
| Effect of exchange rates | 10.0 | 9.0 | 7.0 | -12.0 | -22.0 | -20.0 | — | — |
| Net change in cash | 800 | -2,113 | -1,249 | -6,453 | 7,367 | 551 | — | — |
| Free cash flow | 2,078 | 1,683 | 1,683 | 4,595 | 617 | 2,093 | — | — |
| Levered free cash flow | 2,004 | 608 | 1,967 | 1,952 | 11,886 | 1,071 | — | — |